Article
APOL1 genotype, blood pressure, and survival in African Americans with nondiabetic nephropathy.
Kidney international - 1 Feb 2017
Robinson Todd W, Freedman Barry I
Abstract excerpt
Several landmark trials have assessed the effects of aggressive hypertension control on the progression of nondiabetic chronic kidney disease. Results generally have been disappointing. With the realization that lowering blood pressure, including with renin-angiotensin system blockade, failed to reliably prevent end-stage kidney disease, studies now are analyzing longer-term effects of hypertension control on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
